Functional Evaluation and Characterization of a Newly Developed Silicone Oil-Free Prefillable Syringe System
暂无分享,去创建一个
Yoshihiko Abe | Kazuhiro Iwasaki | Y. Abe | Kaori Funatsu | Koji Nakamura | Arisa Yamashita | Shigeru Suzuki | Keisuke Yoshino | Yukie Kanazawa | Tsuyoshi Yoshimoto | K. Iwasaki | Koji Nakamura | Arisa Yamashita | Shigeru Suzuki | Keisuke Yoshino | Y. Kanazawa | Kaori Funatsu | Tsuyoshi Yoshimoto
[1] Dean C Ripple,et al. Protein particles: what we know and what we do not know. , 2012, Journal of pharmaceutical sciences.
[2] Theodore W Randolph,et al. Silicone oil- and agitation-induced aggregation of a monoclonal antibody in aqueous solution. , 2009, Journal of pharmaceutical sciences.
[3] Jared S. Bee,et al. Ionic strength affects tertiary structure and aggregation propensity of a monoclonal antibody adsorbed to silicone oil-water interfaces. , 2013, Journal of pharmaceutical sciences.
[4] E. Chantelau,et al. Silicone Oil Released From Disposable Insulin Syringes , 1986, Diabetes Care.
[5] Jared S. Bee,et al. The future of protein particle characterization and understanding its potential to diminish the immunogenicity of biopharmaceuticals: a shared perspective. , 2012, Journal of pharmaceutical sciences.
[6] N. Dixit,et al. The effect of Tween(®) 20 on silicone oil-fusion protein interactions. , 2012, International journal of pharmaceutics.
[7] A. Dawson,et al. INSULIN SYRINGES AND SILICONE OIL , 1985, The Lancet.
[8] Wei Wang,et al. Protein aggregation--pathways and influencing factors. , 2010, International journal of pharmaceutics.
[9] C. R. Middaugh,et al. Silicone oil induced aggregation of proteins. , 2005, Journal of pharmaceutical sciences.
[10] J. Fuller. European Community Concerted Action Programme in Diabetes (EURODIAB) , 1989, Diabetic medicine : a journal of the British Diabetic Association.
[11] R. K. Bernstein. Clouding and Deactivation of Clear (Regular) Human Insulin: Association With Silicone Oil From Disposable Syringes? , 1987, Diabetes Care.
[12] P. Kolhe,et al. Development of Biotechnology Products in Pre-filled Syringes: Technical Considerations and Approaches , 2011, AAPS PharmSciTech.
[13] Yong Quan,et al. Mechanistic Understanding of Protein-Silicone Oil Interactions , 2012, Pharmaceutical Research.
[14] S. Singh,et al. An industry perspective on the monitoring of subvisible particles as a quality attribute for protein therapeutics. , 2010, Journal of pharmaceutical sciences.
[15] Hanns-Christian Mahler,et al. Protein aggregation: pathways, induction factors and analysis. , 2009, Journal of pharmaceutical sciences.
[16] R. Baldwin. Contamination of Insulin by Silicone Oil: a Potential Hazard of Plastic Insulin Syringes , 1988, Diabetic medicine : a journal of the British Diabetic Association.
[17] Vincent J. Sullivan,et al. Evaluation of the effect of syringe surfaces on protein formulations. , 2011, Journal of pharmaceutical sciences.
[18] Chi-Ting Huang,et al. Quantitation of protein particles in parenteral solutions using micro-flow imaging. , 2009, Journal of pharmaceutical sciences.